Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-02

FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride from Aurobindo Pharma Limited, confirming labeling for this generic antiemetic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON HYDROCHLORIDE (ONDANSETRON HYDROCHLORIDE)